Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00192959Phase 3Completed
Phase 3, randomised trial of xenon in Anesthesia (2 arms), sponsored by Rigshospitalet. Primary endpoint: Combined score of cognitive function tests. Started Mar 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00192959.